Antithrombotic Clinical Trial
Effectiveness of the Application on Individualized Antithrombotic Therapy in Chinese Patients With Coronary Artery Disease
|Source||Guangdong General Hospital|
|Contact||Jiyan Chen, M.D.|
|Start date||November 1, 2017|
|Completion date||December 20, 2020|
Develop an exemplary anti-thrombotic therapy network data platform and a intelligent terminal application(APP), establish an new pattern used in long-time anti-thrombotic management based on dynamic risk evaluation, and promoted and verified by 10 thousands large sample's cohort study.
1.1.Develop and optimize antithrombotic therapy network data platform and thrombotic risk
evaluate intelligent terminal APP, establish an new pattern based on dynamic risk evaluation
and event triggered response, settle the conundrum in clinical practice about antithrombotic
therapy such as poor compliance,lag and unreasonable in drug adjustment.
1.2.Settle the technical problem that intelligent terminal APP code isn't compatible with most tablet PCs and smart phones.
1.3.Impel the data platform rendock and integrate with the daily medical system, enhance it's accuracy,compatibility,privacy and quality standard.
1.4.Promote the new pattern about anti-thrombotic management by large sample's cohort study, increase the patients' compliance, reduce the readmission rate and adverse event rate of heart and cerebral vessels.
||Phase 1/Phase 2|